Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 786353, 9 pages
http://dx.doi.org/10.1155/2014/786353
Clinical Study

Clinical Outcomes after Treatment of Periodontal Intrabony Defects with Nanocrystalline Hydroxyapatite (Ostim) or Enamel Matrix Derivatives (Emdogain): A Randomized Controlled Clinical Trial

Department of Periodontology, Medical Faculty Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany

Received 20 September 2013; Revised 5 December 2013; Accepted 25 December 2013; Published 9 February 2014

Academic Editor: Poramate Pitak-Arnnop

Copyright © 2014 Elyan Al Machot et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Elyan Al Machot, Thomas Hoffmann, Katrin Lorenz, Ihssan Khalili, and Barbara Noack, “Clinical Outcomes after Treatment of Periodontal Intrabony Defects with Nanocrystalline Hydroxyapatite (Ostim) or Enamel Matrix Derivatives (Emdogain): A Randomized Controlled Clinical Trial,” BioMed Research International, vol. 2014, Article ID 786353, 9 pages, 2014. https://doi.org/10.1155/2014/786353.